123 related articles for article (PubMed ID: 14677677)
1. Vaccines and companion diagnostic tests for foot-and-mouth disease virus. An overview of the experience in South America.
Bergmann IE; Malirat V; Neitzert E; Correa Melo E
Dev Biol (Basel); 2003; 114():59-65. PubMed ID: 14677677
[TBL] [Abstract][Full Text] [Related]
2. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
Bergmann IE; Malirat V; Neitzert E
Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
[TBL] [Abstract][Full Text] [Related]
3. Vaccination: foot-and-mouth disease experience in South America.
Bergmann IE; Malirat V; Neitzert E; Correa Melo E
Dev Biol (Basel); 2004; 119():273-82. PubMed ID: 15742639
[TBL] [Abstract][Full Text] [Related]
4. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines.
Bergmann IE; Neitzert E; Malirat V; de Mendonça Campos R; Pulga M; Muratovik R; Quintino D; Morgados JC; Oliveira M; de Lucca Neto D
Dev Biol (Basel); 2006; 126():241-50; discussion 327. PubMed ID: 17058500
[TBL] [Abstract][Full Text] [Related]
5. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
Bergmann IE; Malirat V; Falczuk AJ
Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
[TBL] [Abstract][Full Text] [Related]
6. Vaccines and foot-and-mouth disease eradication in South America.
Saraiva V
Dev Biol (Basel); 2003; 114():67-77. PubMed ID: 14677678
[TBL] [Abstract][Full Text] [Related]
7. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
8. [Foot-and-mouth disease:: an old disease--new solutions].
Pastoret PP
Bull Mem Acad R Med Belg; 2005; 160(1-2):103-8; discussion 108. PubMed ID: 16116814
[TBL] [Abstract][Full Text] [Related]
9. The use of vaccines in South American foot-and-mouth disease eradication programmes.
Saraiva V; Darsie G
Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
[TBL] [Abstract][Full Text] [Related]
10. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
11. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
12. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
13. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
[TBL] [Abstract][Full Text] [Related]
14. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
[TBL] [Abstract][Full Text] [Related]
15. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
16. Engineering better vaccines for foot-and-mouth disease.
Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
[TBL] [Abstract][Full Text] [Related]
17. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a bovine serum evaluation panel as a standard for immunoassays based on detection of antibodies against foot-and-mouth disease viral non-capsid proteins.
Campos Rde M; Malirat V; Neitzert E; Grazioli S; Brocchi E; Sanchez C; Falczuk AJ; Ortiz S; Rebello MA; Bergmann IE
J Virol Methods; 2008 Jul; 151(1):15-23. PubMed ID: 18499275
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against foot and mouth disease reduces virus transmission in groups of calves.
Orsel K; Dekker A; Bouma A; Stegeman JA; de Jong MC
Vaccine; 2005 Sep; 23(41):4887-94. PubMed ID: 16002192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
